Moody's expects to lower its U.S. credit rating to Aa1 from Aaa in 2013 unless budget negotiations "produce a stabilization and then downward trend" in the government's debt/GDP ratio. [View news story]
The housing crisis was caused by Clinton not Bush.
Your points are stated well but have you considered that the companies in S&P on average get 41% of their revenue from overseas.
Despite what progress consumers have made in debt reduction the quantity of jobs created in the US is sub par. <100K in August and the 8.1% is more like 15% if you count folks that no longer are claiming unemployment. Probably more like 22% if you consider under employed as well.
Greece, 24%, Spain 25%, Italy and many other countries also very high.
Consider the recent actions of the ECB and potential QE3 Fed buying and holding debt. The debt purchased from Greece was 75% written off because of shrinking GDP and high unemployment. Greece is wavering on exiting the Euro and Germany is considering easing or changing the plan again. Ok, so Greece is not a big deal and is peanuts in comparison to other countries. So Spain is next, a country with bond rates that have come close to the breaking point of 7%. Then maybe Italy is next beyond this and the ECB wants to keep things together so they buy the debt and then what? Is this Greece all over but with much bigger numbers at risk? Greece took a couple months to figure out last time and is still in big trouble.
A bigger near term VIX catalyst is Germany saying no to this program this week? Without the backing of Germany what's going to happen to the bond buying program?
The US has Bernanke talking about QE3, as an attempt to solve job creation. They can manipulate stuff make things attractive, but to create jobs means changes are needed in Washington. BB made comments on this and my opinion is that under current leadership this is not going to happen. The real issues are not being solved. The ECB and Fed are using gold plated bandaids when they need a doctor to stitch the wounds.
In a couple months the budget deficit (fiscal cliff) hits the fan once again. Last time the politicians could not resolve anything and kicked the can down the road. Well here we are again after a downgrade looking at an even bigger deficit. The government simple does not know how to stop spending money, champagne taste bear wallet! So consumer debt is under control and government debt is at all time high. What do you suppose the outcome of the national debt is within a couple months, higher taxes on a down economy with high unemployment?
Current government is adding regulations and departments to oversee the policies growing the debt and core issues. Wasn't the campaign promise is if we spend this 883B$ we would never see south of 7.5% unemployment? How much did they waste on alternative energy and in turn blocked developing Oil and Gas in the US? Also the pipeline between Canada and US blocked? The list goes on and on with regards to how Washington is against business development and job creation.
Over the next 2 months we will see what happens to the VIX and if it stays in the low 14-15 range.
I agree some things are better, but in the overall picture no, getting worse. The lower VIX is a byproduct of trying to solve issues by throwing money at the problem and in turn not solving anything.
Today's Market News To Trade On: 5 Stocks Moving On News [View article]
The fundamentals in emerging Bio is the pipeline not the balance sheet. Take a look at PCYC, they also do not have any revenue from sales except a robust pipeline and partner.
More Downside Expected In Peregrine Pharmaceuticals [View article]
So why the article yesterday from Thestreet on PPHM once again? It had little impact since it was the 5th within a short period... And I thought AF was busy chasing rats.....
Peregrine Pharmaceuticals (PPHM +15%) continue to rise ahead of its September 7 presentation at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, where the drug developer will present Phase II trial data for bavituximab, its drug candidate to treat non-small cell lung cancer. [View news story]
For sure, the article by AF yesterday clearly impacted those that do not read or understand the details what is going. The most illogical assumption is the data being presented has no significance. This was a late entry, scrutinized by colleagues and has to meet exceptional cause for late submission. NOPE they must all be lying!
Low volatility may be here to stay, argues BNP's Gerry Fowler, the result of an "extreme" risk-on, risk-off environment where investors sit on their hands until some central banker or government official utters something. The resulting high volatility on just a few days makes all other trading sessions snoozers. It's enough to drive even Louis Bacon to the golf course. [View news story]
West Wing, agree with your comments.
The thought that everything in the world is rosy is backed by poor decisions and policy. ECB and FED always buy band-aids not stitches.
Joe NICE call! Still waiting for the dynamite to go off. Perhaps when people realize the snow job they were given this week it will sink in.
Not sure what the ECB is thinking, wasn't Greece enough of a lesson that this fails to work with a shrinking GDP? As far as I know please confirm or correct me but Germany is not yet behind this move on buying the bonds.
Not so wisemc, cheating in baseball and all sports goes way beyond steroids and players caught. This is not the board for debating that. Your response appears as if your thinking I went after Scott with my comment on PPHM above.
To set the record straight, Scott mentioned "The article contends Peregrine's lead drug candidate, bavituximab is not as effective as many say, and the report also questions Peregrine's financial position." He was not stating this but this is his recap of one article written by another individual.
My comment is responding to the financial situation stated by authors that are shorting the stock and writing damning articles for their own short term gain. Over the last month at least 4 articles were written with negative opinions on PPHM from financial opinions to effectiveness of the drugs in the pipeline.
Scott goes on to state "On the surface this drug looks promising, so I encourage potential investors in Perigene to do careful and complete due diligence to consider both the bull and bear case -- for and against the company."
Since he wrote this article PPHM secured the financing and also notified folks of 2 conferences discussing the trials.
The proof of how well this drug works and the trials of other drugs in the pipeline is partially answered in the presentation yesterday.
Tomorrow the presentation in the Chicago Oncology meeting will show everyone how well it works from a technical review of trial data to date.
Moody's expects to lower its U.S. credit rating to Aa1 from Aaa in 2013 unless budget negotiations "produce a stabilization and then downward trend" in the government's debt/GDP ratio. [View news story]
Don't Be Puzzled By The Low VIX [View article]
Your points are stated well but have you considered that the companies in S&P on average get 41% of their revenue from overseas.
Despite what progress consumers have made in debt reduction the quantity of jobs created in the US is sub par. <100K in August and the 8.1% is more like 15% if you count folks that no longer are claiming unemployment. Probably more like 22% if you consider under employed as well.
Greece, 24%, Spain 25%, Italy and many other countries also very high.
Consider the recent actions of the ECB and potential QE3 Fed buying and holding debt. The debt purchased from Greece was 75% written off because of shrinking GDP and high unemployment.
Greece is wavering on exiting the Euro and Germany is considering easing or changing the plan again. Ok, so Greece is not a big deal and is peanuts in comparison to other countries. So Spain is next, a country with bond rates that have come close to the breaking point of 7%. Then maybe Italy is next beyond this and the ECB wants to keep things together so they buy the debt and then what? Is this Greece all over but with much bigger numbers at risk? Greece took a couple months to figure out last time and is still in big trouble.
A bigger near term VIX catalyst is Germany saying no to this program this week? Without the backing of Germany what's going to happen to the bond buying program?
The US has Bernanke talking about QE3, as an attempt to solve job creation. They can manipulate stuff make things attractive, but to create jobs means changes are needed in Washington. BB made comments on this and my opinion is that under current leadership this is not going to happen. The real issues are not being solved. The ECB and Fed are using gold plated bandaids when they need a doctor to stitch the wounds.
In a couple months the budget deficit (fiscal cliff) hits the fan once again. Last time the politicians could not resolve anything and kicked the can down the road. Well here we are again after a downgrade looking at an even bigger deficit.
The government simple does not know how to stop spending money, champagne taste bear wallet! So consumer debt is under control and government debt is at all time high. What do you suppose the outcome of the national debt is within a couple months, higher taxes on a down economy with high unemployment?
Current government is adding regulations and departments to oversee the policies growing the debt and core issues. Wasn't the campaign promise is if we spend this 883B$ we would never see south of 7.5% unemployment? How much did they waste on alternative energy and in turn blocked developing Oil and Gas in the US? Also the pipeline between Canada and US blocked? The list goes on and on with regards to how Washington is against business development and job creation.
Over the next 2 months we will see what happens to the VIX and if it stays in the low 14-15 range.
I agree some things are better, but in the overall picture no, getting worse. The lower VIX is a byproduct of trying to solve issues by throwing money at the problem and in turn not solving anything.
Today's Market News To Trade On: 5 Stocks Moving On News [View article]
More Downside Expected In Peregrine Pharmaceuticals [View article]
Peregrine: Bavi Results Are Overhyped And Inconclusive [View article]
Today's Market News To Trade On: 5 Stocks Moving On News [View article]
More Downside Expected In Peregrine Pharmaceuticals [View article]
And I thought AF was busy chasing rats.....
More Downside Expected In Peregrine Pharmaceuticals [View article]
Small Cap BioPharma Currents [View article]
PPHM trading halted a few minutes ago for some news.....
Peregrine Pharmaceuticals (PPHM +15%) continue to rise ahead of its September 7 presentation at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, where the drug developer will present Phase II trial data for bavituximab, its drug candidate to treat non-small cell lung cancer. [View news story]
Low volatility may be here to stay, argues BNP's Gerry Fowler, the result of an "extreme" risk-on, risk-off environment where investors sit on their hands until some central banker or government official utters something. The resulting high volatility on just a few days makes all other trading sessions snoozers. It's enough to drive even Louis Bacon to the golf course. [View news story]
The thought that everything in the world is rosy is backed by poor decisions and policy. ECB and FED always buy band-aids not stitches.
Joe NICE call! Still waiting for the dynamite to go off. Perhaps when people realize the snow job they were given this week it will sink in.
Stocks Stall Mid-Day As VIX Jumps Off The Most Recent Lows [View instapost]
Teva: Undervalued Industry Leading Generic Drug Maker At 7.5X Adjusted EPS [View article]
QE3, A Prudent Investment Strategy [View article]
Not sure what the ECB is thinking, wasn't Greece enough of a lesson that this fails to work with a shrinking GDP? As far as I know please confirm or correct me but Germany is not yet behind this move on buying the bonds.
Small Cap BioPharma Currents [View article]
To set the record straight, Scott mentioned "The article contends Peregrine's lead drug candidate, bavituximab is not as effective as many say, and the report also questions Peregrine's financial position." He was not stating this but this is his recap of one article written by another individual.
My comment is responding to the financial situation stated by authors that are shorting the stock and writing damning articles for their own short term gain. Over the last month at least 4 articles were written with negative opinions on PPHM from financial opinions to effectiveness of the drugs in the pipeline.
Scott goes on to state "On the surface this drug looks promising, so I encourage potential investors in Perigene to do careful and complete due diligence to consider both the bull and bear case -- for and against the company."
Since he wrote this article PPHM secured the financing and also notified folks of 2 conferences discussing the trials.
The proof of how well this drug works and the trials of other drugs in the pipeline is partially answered in the presentation yesterday.
Tomorrow the presentation in the Chicago Oncology meeting will show everyone how well it works from a technical review of trial data to date.